Rifamycin action on RNA polymerase in antibiotic-tolerantMycobacterium tuberculosisresults in differentially detectable populations
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rifamycin action on RNA polymerase in antibiotic-tolerantMycobacterium tuberculosisresults in differentially detectable populations
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 24, Pages E4832-E4840
Publisher
Proceedings of the National Academy of Sciences
Online
2017-05-31
DOI
10.1073/pnas.1705385114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Evidence for the Complexity of the Population Structure ofMycobacterium tuberculosisIncreases the Diagnostic and Biologic Challenges
- (2016) Véronique Dartois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis
- (2016) Melissa D. Chengalroyen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
- (2016) Yanmin Hu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of anIn VitroAssay for Detection of Drug-Induced Resuscitation-Promoting-Factor-Dependent Mycobacteria
- (2016) Jessica Loraine et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs
- (2016) Obolbek Turapov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
- (2016) Payam Nahid et al. CLINICAL INFECTIOUS DISEASES
- Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
- (2016) Roger K. Verbeeck et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline
- (2016) Moloko C. Cholo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mechanisms of bacterial persistence during stress and antibiotic exposure
- (2016) Alexander Harms et al. SCIENCE
- The essential mycobacterial amidotransferase GatCAB is a modulator of specific translational fidelity
- (2016) Hong-Wei Su et al. Nature Microbiology
- Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS
- (2016) Carolline Araújo-Mariz et al. PLoS One
- Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis
- (2015) Ben Gold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dormant non-culturable Mycobacterium tuberculosis retains stable low-abundant mRNA
- (2015) Dmitriy V. Ignatov et al. BMC GENOMICS
- Stress and Host Immunity Amplify Mycobacterium tuberculosis Phenotypic Heterogeneity and Induce Nongrowing Metabolically Active Forms
- (2015) Giulia Manina et al. Cell Host & Microbe
- Differential Influence of Nutrient-Starved Mycobacterium tuberculosis on Adaptive Immunity Results in Progressive Tuberculosis Disease and Pathology
- (2015) Jes Dietrich et al. INFECTION AND IMMUNITY
- Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum
- (2015) M. Ayrapetyan et al. INFECTION AND IMMUNITY
- Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
- (2015) Rodney Dawson et al. LANCET
- The association between sterilizing activity and drug distribution into tuberculosis lesions
- (2015) Brendan Prideaux et al. NATURE MEDICINE
- High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo
- (2015) Yanmin Hu et al. Frontiers in Microbiology
- Sterilizing Activity of Thioridazine in Combination with the First-Line Regimen against Acute Murine Tuberculosis
- (2014) Noton K. Dutta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
- (2014) Abdullah Alsultan et al. DRUGS
- Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states
- (2014) E. G. Salina et al. Open Biology
- The importance of the viable but non-culturable state in human bacterial pathogens
- (2014) Laam Li et al. Frontiers in Microbiology
- Efficacy of Nitazoxanide against Clinical Isolates of Mycobacterium tuberculosis
- (2013) Kristina Shigyo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduced Drug Uptake in Phenotypically Resistant Nutrient-Starved Nonreplicating Mycobacterium tuberculosis
- (2013) Jansy Sarathy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
- (2013) Philana Ling Lin et al. NATURE MEDICINE
- Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel
- (2012) Krishna Kannan et al. CELL
- Resistance to environmental stresses byVibrio vulnificusin the viable but nonculturable state
- (2012) Joanna Nowakowska et al. FEMS MICROBIOLOGY ECOLOGY
- Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
- (2012) B. Gold et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fresh Approaches to Anti-Infective Therapies
- (2012) C. Nathan Science Translational Medicine
- Mycobacterium tuberculosis Can Utilize Heme as an Iron Source
- (2011) C. M. Jones et al. JOURNAL OF BACTERIOLOGY
- Dormant ovoid cells of Mycobacterium tuberculosis are formed in response to gradual external acidification
- (2011) Margarita O. Shleeva et al. TUBERCULOSIS
- Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis
- (2011) Shinya Watanabe et al. PLoS Pathogens
- Rifampin Stability in 7H9 Broth and Lowenstein-Jensen Medium
- (2010) X. Yu et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis
- (2010) Dick van Soolingen et al. PLoS One
- Resuscitation-promoting Factors Reveal an Occult Population of Tubercle Bacilli in Sputum
- (2009) Galina V. Mukamolova et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Taming Tuberculosis: A Challenge for Science and Society
- (2009) Carl Nathan Cell Host & Microbe
- Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana
- (2009) Sekai Chideya et al. CLINICAL INFECTIOUS DISEASES
- Nitazoxanide Kills Replicating and NonreplicatingMycobacterium tuberculosisand Evades Resistance
- (2009) Luiz Pedro S. de Carvalho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability
- (2009) M. Gengenbacher et al. MICROBIOLOGY-SGM
- Nitrate Enhances the Survival of Mycobacterium tuberculosis during Inhibition of Respiration
- (2008) C. D. Sohaskey JOURNAL OF BACTERIOLOGY
- Cytological and Transcript Analyses Reveal Fat and Lazy Persister-Like Bacilli in Tuberculous Sputum
- (2008) Natalie J Garton et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now